These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10868478)

  • 1. Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes.
    Meng Q; Qi M; Chen DZ; Yuan R; Goldberg ID; Rosen EM; Auborn K; Fan S
    J Mol Med (Berl); 2000; 78(3):155-65. PubMed ID: 10868478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of Indole-3-carbinol on invasion and migration in human breast cancer cells.
    Meng Q; Goldberg ID; Rosen EM; Fan S
    Breast Cancer Res Treat; 2000 Sep; 63(2):147-52. PubMed ID: 11097090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of chemically modified tetracyclines on proliferation, invasion and migration properties of MDA-MB-468 human breast cancer cells.
    Meng Q; Xu J; Goldberg ID; Rosen EM; Greenwald RA; Fan S
    Clin Exp Metastasis; 2000; 18(2):139-46. PubMed ID: 11235989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple molecular targets of indole-3-carbinol, a chemopreventive anti-estrogen in breast cancer.
    Ashok BT; Chen YG; Liu X; Garikapaty VP; Seplowitz R; Tschorn J; Roy K; Mittelman A; Tiwari RK
    Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S86-93. PubMed ID: 12570340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new indole-3-carbinol tetrameric derivative inhibits cyclin-dependent kinase 6 expression, and induces G1 cell cycle arrest in both estrogen-dependent and estrogen-independent breast cancer cell lines.
    Brandi G; Paiardini M; Cervasi B; Fiorucci C; Filippone P; De Marco C; Zaffaroni N; Magnani M
    Cancer Res; 2003 Jul; 63(14):4028-36. PubMed ID: 12874002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells.
    Fan S; Meng Q; Auborn K; Carter T; Rosen EM
    Br J Cancer; 2006 Feb; 94(3):407-26. PubMed ID: 16434996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-Benzyl-indole-3-carbinol is a novel indole-3-carbinol derivative with significantly enhanced potency of anti-proliferative and anti-estrogenic properties in human breast cancer cells.
    Nguyen HH; Lavrenov SN; Sundar SN; Nguyen DH; Tseng M; Marconett CN; Kung J; Staub RE; Preobrazhenskaya MN; Bjeldanes LF; Firestone GL
    Chem Biol Interact; 2010 Aug; 186(3):255-66. PubMed ID: 20570586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indole-3-carbinol is a negative regulator of estrogen receptor-alpha signaling in human tumor cells.
    Meng Q; Yuan F; Goldberg ID; Rosen EM; Auborn K; Fan S
    J Nutr; 2000 Dec; 130(12):2927-31. PubMed ID: 11110848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of MUC1 expression by indole-3-carbinol.
    Lee IJ; Han F; Baek J; Hisatsune A; Kim KC
    Int J Cancer; 2004 May; 109(6):810-6. PubMed ID: 15027113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective responsiveness of human breast cancer cells to indole-3-carbinol, a chemopreventive agent.
    Tiwari RK; Guo L; Bradlow HL; Telang NT; Osborne MP
    J Natl Cancer Inst; 1994 Jan; 86(2):126-31. PubMed ID: 8271295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indole-3-carbinol inhibits prostate cancer cell migration via degradation of beta-catenin.
    Jeong YM; Li H; Kim SY; Yun HY; Baek KJ; Kwon NS; Myung SC; Kim DS
    Oncol Res; 2011; 19(5):237-43. PubMed ID: 21542459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
    Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
    Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alkyl-lysophospholipid 1-O-octadecyl-2-O-methyl- glycerophosphocholine induces invasion through episialin-mediated neutralization of E-cadherin in human mammary MCF-7 cells in vitro.
    Steelant WF; Goeman JL; Philippé J; Oomen LC; Hilkens J; Krzewinski-Recchi MA; Huet G; Van der Eycken J; Delannoy P; Bruyneel EA; Mareel MM
    Int J Cancer; 2001 May; 92(4):527-36. PubMed ID: 11304687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
    De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
    J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells.
    Sommers CL; Gelmann EP; Kemler R; Cowin P; Byers SW
    Cancer Res; 1994 Jul; 54(13):3544-52. PubMed ID: 8012979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of cell invasion and migration by alcohol in breast cancer cells.
    Meng Q; Gao B; Goldberg ID; Rosen EM; Fan S
    Biochem Biophys Res Commun; 2000 Jul; 273(2):448-53. PubMed ID: 10873626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin.
    Wong AS; Gumbiner BM
    J Cell Biol; 2003 Jun; 161(6):1191-203. PubMed ID: 12810698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. I3C and ICZ inhibit migration by suppressing the EMT process and FAK expression in breast cancer cells.
    Ho JN; Jun W; Choue R; Lee J
    Mol Med Rep; 2013 Feb; 7(2):384-8. PubMed ID: 23179357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indole-3-carbinol downregulation of telomerase gene expression requires the inhibition of estrogen receptor-alpha and Sp1 transcription factor interactions within the hTERT promoter and mediates the G1 cell cycle arrest of human breast cancer cells.
    Marconett CN; Sundar SN; Tseng M; Tin AS; Tran KQ; Mahuron KM; Bjeldanes LF; Firestone GL
    Carcinogenesis; 2011 Sep; 32(9):1315-23. PubMed ID: 21693539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of e-cadherin and catenins in early gastric cancer.
    Joo YE; Rew JS; Choi SK; Bom HS; Park CS; Kim SJ
    J Clin Gastroenterol; 2002 Jul; 35(1):35-42. PubMed ID: 12080224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.